Bisphosphonate - Related Osteonecrosis of the Jaw – Five Years Experience

1. Stanton DC, Balasanian E. Outcome of surgical managment of Bisfosfonate-Related Osteonecrosis of the Jaws: Review of 33 Surgical Cases. J Oral Maxillofac Surg 2009 (67): 943−950.10.1016/j.joms.2008.12.057Search in Google Scholar

2. Ruggiero SL, Dodson TB, Assael LA, Landesberg B, Marx RE, Mehrota B. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisfosfonate-Related Osteonacrosis of the Jaws-2009 Update. J Oral Maxillofac Surg 2009, Suppl 1 (67): 2−12.10.1016/j.joms.2009.01.009Search in Google Scholar

3. Marx RE. Pamidronate (Aredia) and Zolendronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg 2003 (61): 1 115.10.1016/S0278-2391(03)00720-1Search in Google Scholar

4. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004 (62): 527-34.10.1016/j.joms.2004.02.004Search in Google Scholar

5. Advisory Task Force on Bisfosfonate-Related Osteonacrosis of the Jaws. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisfosfonate-Related Osteonacrosis of the Jaws. J Oral Maxillofac Surg 2007 (65): 369.10.1016/j.joms.2006.11.003Search in Google Scholar

6. Abu-Id MH, Warnke PH, Gottschalk J, Springer I, Wiltfang J, Acil Y, Russo PAJ, Kreutsch T. “Bis-phossy jaws” - High and low risk factors for bisphosphonate-induced osteonecrosis of the jaw, J Oral Maxillofac Surg 2008 (36):95-103.10.1016/j.jcms.2007.06.008Search in Google Scholar

7. Tubiana-Hulin M, et al. Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis. Crit Rev Oncol/Hematol (2008), doi:10.1016/j.critrevonc.2008.10.00910.1016/j.critrevonc.2008.10.009Search in Google Scholar

8. Allen MR, Burr DB. The Pathogenesis of Bisfosfonate-Related Osteonecrosis of the Jaw: So many Hypotheses, So Few Data, J Oral Maxillofac Surg 2009, Suppl 1 (67): 61−70.10.1016/j.joms.2009.01.007Search in Google Scholar

9. Sonis ST, Watkins BA, Lyng GD, Lerman MA, Anderson KC. Bony changes in the jaws of rats treated with zolendronic acid and dexamethazone before dental extractions mimic bisphosphonate-realted osteonecrosis in cancer patients. Oral Oncology 2009 (45):164-172.10.1016/j.oraloncology.2008.04.013Search in Google Scholar

10. Allen MR, Burr DB. Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. J Oral Maxillofac Surg 2008 (66): 987.10.1016/j.joms.2008.01.038Search in Google Scholar

11. Assael LA. Oral Bisfosfonates as a Ceuse of Bisphosphonate-Related Osteonecrosis of the Jaws: Clinical Findings, Assessment of risks, and Preventive Strategies. J Oral Maxillofac Surg 2009, Suppl 1 (67): 35−43.10.1016/j.joms.2009.01.003Search in Google Scholar

12. Capsoni F, Longhi M, Weinstein R. Bisphophonate-associated necrosis of the jaw> the rheumathologist’s role. Arthritis Res Ther 2006 (8):219.10.1186/ar2050Search in Google Scholar

13. Woo SB, Hellstein JW, Kalmar JR. Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws. Ann Intern Med 2006 (144):753-61.10.7326/0003-4819-144-10-200605160-00009Search in Google Scholar

14. Woolhorton E. Patients retrieving intravenous bisphosphonates should avoid invasive dental procedures. CMAJ 172:1684, 200510.1503/cmaj.050640Search in Google Scholar

15. Otto S, et al., Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: Not just a sporadic..., Journal of Cranio-Maxillo-Facial Surgery 2010, doi:10.1016/j.jcms.2010.05.00910.1016/j.jcms.2010.05.009Search in Google Scholar

16. Arce K, Assael LA, Weissman JL, Markiewitz MR. Imaging Findings in Bisfosfonate-Related Osteonecrosis of Jaws. J Oral Maxillofac Surg 2009, Suppl 1 (67): 75−84.10.1016/j.joms.2008.12.002Search in Google Scholar

17. Landesberg R, Cozin M, Cremers S, Woo V,Kousteni S, Sinha S, Garrett-Sinha L, Raghavan S. IInhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg 2008 (66):839-47.10.1016/j.joms.2008.01.026Search in Google Scholar

18. Scheper MA, Badros A, Chaisuparat R, Cullen KJ, Meiller TF. Effect of zolendronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. British Journal of Haematology, 2008, doi: 10.1111/j.1365-2141.2008.07504.x10.1111/j.1365-2141.2008.07504.xSearch in Google Scholar

19. Kobayashi Y, Hiraga T, Ueda A, Wang L, Matsumoto-Nakano M, Hata K, Yatani H, Yoneda T. Yolendronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, withou causing osteonecrosis, in mice. J Bone Miner Metab 2010 (28):165-175.10.1007/s00774-009-0128-9Search in Google Scholar

20. Hansen T, Kunkel M, Springer E, Walter C, Weber A, Siegel E, Kirkpatrick CJ. Actinomycosis of the jaws - histopathological study of 45 patients shows involvement in bisphophonate-associated osteonecrosis and infected osteoradionecrosis. Virchows Arch. 451:1009-1017, 200710.1007/s00428-007-0516-2Search in Google Scholar

21. Gliklich R, Wilson J. Epidemiology of Bisphosphonate-Related Osteonecrosis of the Jaws: The Utility of a National Registry. J Oral Maxillofac Surg 2009 Suppl 1 (67): 71−74.10.1016/j.joms.2009.01.005Search in Google Scholar